pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Christina Applegate’s misdiagnosis highlights ongoing challenges in multiple sclerosis diagnosis

Oct 24, 2026·read at STAT ↗Neutral

Actor Christina Applegate, who was diagnosed with multiple sclerosis five years ago, recently disclosed that she was initially misdiagnosed. Her public story puts a human face on the difficulty doctors face in accurately identifying the disease.

Bruce Bebo, chief research and medical affairs officer at the National Multiple Sclerosis Society, notes that while imaging, biomarkers, and updated diagnostic criteria have allowed earlier detection, many patients still endure years of uncertainty or receive incorrect diagnoses.

The opinion piece stresses that speed alone should not drive the diagnostic process. Accurate identification is essential to start effective treatment before irreversible neurological damage occurs.

Bebo calls for continued refinement of diagnostic tools and greater awareness among clinicians to balance early detection with precision, ensuring patients receive the right diagnosis at the right time.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Christina Applegate puts a face on one of the most consequential challenges in neurology”

read at STAT ↗
1,067 words · retrieved 33m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATHUNIQUE
topics
Neurology14Multiple Sclerosis9Diagnostics CompanyOncologyOphthalmologyPain

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 21h agoTango plans 14% workforce cut, mainly of research staffBioSpace
  • Aug 17How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and MedicineBioSpace
  • 1h agoOpinion: STAT readers on Elizabeth Holmes, cancer screening, and moreSTAT
  • 1d agoRoche’s pipeline trim claims Poseida’s off-the-shelf CAR T assetBioSpace